Search research articles
Contact Us
Filters
Showing results (31-40 of 256) with videos related to
Page
of 26
Sort By:
Virus Research
|
October 11, 2005
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma
Fernando Abaitua, Juan Ramón Rodríguez, Ana Garzón, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
April 15, 2024
Current situation in the development of a preventive HIV vaccine
José Alcamí, Joan Joseph Munné, María Ángeles Muñoz-Fernández, et al.
Plos Pathogens
|
July 8, 2008
Vaccinia virus E3 protein prevents the antiviral action of ISG15
Susana Guerra, Ana Cáceres, Klaus-Peter Knobeloch, et al.
Cellular Microbiology
|
August 22, 2007
Membrane cell fusion activity of the vaccinia virus A17-A27 protein complex
Grazyna Kochan, David Escors, José Manuel González, et al.
Vaccine
|
May 19, 2009
Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
Carmen E Gómez, José L Nájera, Raquel Sánchez, et al.
Journal of Virology
|
April 21, 2017
Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response
Mauro Di Pilato, Ernesto Mejías-Pérez, Carlos Oscar S Sorzano, et al.
Journal of Virology
|
January 7, 2014
Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens
Juan García-Arriaza, Carmen E Gómez, Carlos Óscar S Sorzano, et al.
Plos One
|
February 12, 2011
Diversity in viral anti-PKR mechanisms: a remarkable case of evolutionary convergence
Elena Domingo-Gil, René Toribio, José Luis Nájera, et al.
Current Gene Therapy
|
April 2, 2011
MVA and NYVAC as vaccines against emergent infectious diseases and cancer
Carmen E Gómez, José L Nájera, Magdalena Krupa, et al.
Anales De Pediatria
|
February 17, 2024
Thirty-day readmissions in children with complex chronic conditions
Daiana Basso, Carolina Bermúdez, Vanessa Carpio, et al.
Page
of 26
Search research articles
Search
Showing results (31-40 of 256) with videos related to
Sort By:
Page
of 26
Virus Research
|
October 11, 2005
Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma
Fernando Abaitua, Juan Ramón Rodríguez, Ana Garzón, et al.
Enfermedades Infecciosas Y Microbiologia Clinica
|
April 15, 2024
Current situation in the development of a preventive HIV vaccine
José Alcamí, Joan Joseph Munné, María Ángeles Muñoz-Fernández, et al.
Plos Pathogens
|
July 8, 2008
Vaccinia virus E3 protein prevents the antiviral action of ISG15
Susana Guerra, Ana Cáceres, Klaus-Peter Knobeloch, et al.
Cellular Microbiology
|
August 22, 2007
Membrane cell fusion activity of the vaccinia virus A17-A27 protein complex
Grazyna Kochan, David Escors, José Manuel González, et al.
Vaccine
|
May 19, 2009
Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
Carmen E Gómez, José L Nájera, Raquel Sánchez, et al.
Journal of Virology
|
April 21, 2017
Distinct Roles of Vaccinia Virus NF-κB Inhibitor Proteins A52, B15, and K7 in the Immune Response
Mauro Di Pilato, Ernesto Mejías-Pérez, Carlos Oscar S Sorzano, et al.
Journal of Virology
|
January 7, 2014
Deletion of the vaccinia virus N2L gene encoding an inhibitor of IRF3 improves the immunogenicity of modified vaccinia virus Ankara expressing HIV-1 antigens
Juan García-Arriaza, Carmen E Gómez, Carlos Óscar S Sorzano, et al.
Plos One
|
February 12, 2011
Diversity in viral anti-PKR mechanisms: a remarkable case of evolutionary convergence
Elena Domingo-Gil, René Toribio, José Luis Nájera, et al.
Current Gene Therapy
|
April 2, 2011
MVA and NYVAC as vaccines against emergent infectious diseases and cancer
Carmen E Gómez, José L Nájera, Magdalena Krupa, et al.
Anales De Pediatria
|
February 17, 2024
Thirty-day readmissions in children with complex chronic conditions
Daiana Basso, Carolina Bermúdez, Vanessa Carpio, et al.
Page
of 26